Cingulate Inc. Struggles Amid Nasdaq Volatility Amidst Biopharmaceutical Challenges
Cingulate Inc., a clinical-stage biopharmaceutical company, faces significant financial and operational challenges as it navigates the complex landscape of the healthcare sector.
2 minutes to read